The International Liver Congress (ILC 2021), convened by the European Association for the Study of the Liver (EASL), was held virtually on 23-26 June 2021.
Here are selected highlights from ILC 2021:
- WHO releases first-ever global guidance for country validation of viral hepatitis B and C elimination (June 25)
- EASL: Advances in new drugs for curing hepatitis B and hepatitis D announced at ILC 2021 (June 24)
- EASL: Treatment advances for Non-Alcoholic Fatty Liver Disease (NAFLD) announced at ILC 2021 (June 25)
- Health Policy Watch: Leading researchers highlight the impact of COVID-19 on global liver disease (June 24)
Pharma companies at ILC 2021:
- Gilead Sciences: Treatment with Hepcludex® (bulevirtide) was shown to achieve significant response in chronic hepatitis delta virus after 24 weeks (June 24)
- Vir Biotechnology presents new clinical data from ongoing trials of VIR-2218 and VIR-3434 in patients with chronic hepatitis B virus infection at the International Liver Congress 2021 (June 25)
- Virion Therapeutics presents data showing enhanced and sustained virus declines in animals upon immunization with VRON-0200, a therapeutic vaccine for chronic hepatitis B virus (HBV) infections at the International Liver Congress (ILC) (June 25)
- Arbutus announces new data on AB-729 and AB-836 programs with presentation of five abstracts at the EASL International Liver Congress™ 2021 – all selected for best of ILC™ (June 26)
POZ: Hepatitis B study revisits link between tenofovir and COVID-19
infohep reports:
- Antiviral treatments for hepatitis B may reduce severity of COVID-19 or risk of infection
- Advanced cirrhosis or alcohol use disorder raised the risk of COVID-19 death in France
- Bulevirtide appears safe and effective for hepatitis D
- Reflex testing successfully uncovers hidden hepatitis C cases in Scotland
- Peer support improved hepatitis C treatment uptake and completion in England
NATAP reports: click here to access all reports
Healio reports: click here to access all reports
MedPage Today reports: click here to access all reports
SEE ALSO: 2021 International Liver Congress: Updates Day 1 (June 23)
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.